Compounds > vinpocetine
Page last updated: 2024-08-26

vinpocetine and Aura

vinpocetine has been researched along with Aura in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's1 (14.29)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Ahring, P; Chebib, M; Gardella, E; Gjerulfsen, CE; Johannesen, KM; Liao, VWY; Mieszczanek, TS; Møller, RS; Nørby, HAJ; Rubboli, G1
Boyd, A; Illamola, SM; Ivanisevic, M; Leeman-Markowski, B; Lin, C; Loring, DW; Marino, S; Meador, KJ; Medina, AE; Novak, G; Razavi, B; Seliger, J1
Aldana, BI; Chiu, LM; Guarneros, A; Sanchez-Tafolla, BM; Sitges, M1
Nekrassov, V; Sitges, M2
Dutov, AA; Fedetova, AA; Gol'tvanitsa, VA; Temnikova, IV1
Dutov, AA; Gladun, VN; Petrov, AP; Tolpyshev, BA1

Trials

1 trial(s) available for vinpocetine and Aura

ArticleYear
Vinpocetine, cognition, and epilepsy.
    Epilepsy & behavior : E&B, 2021, Volume: 119

    Topics: Adult; Animals; Cognition; Epilepsies, Partial; Epilepsy; Humans; Memory; Mice; Vinca Alkaloids

2021

Other Studies

6 other study(ies) available for vinpocetine and Aura

ArticleYear
Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.
    Annals of clinical and translational neurology, 2023, Volume: 10, Issue:8

    Topics: Autism Spectrum Disorder; Epilepsy; Humans; Quality of Life; Receptors, GABA-A; Vinca Alkaloids

2023
Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs.
    Epilepsy research, 2011, Volume: 96, Issue:3

    Topics: 4-Aminopyridine; Animals; Anticonvulsants; Calcium; Carbamazepine; Drug Interactions; Epilepsy; Fructose; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; In Vitro Techniques; Lamotrigine; Male; Nerve Endings; Oxcarbazepine; Phenytoin; Potassium Channel Blockers; Rats; Rats, Wistar; Sodium; Sodium Channel Blockers; Tetrodotoxin; Topiramate; Triazines; Tritium; Vinca Alkaloids

2011
Vinpocetine inhibits the epileptic cortical activity and auditory alterations induced by pentylenetetrazole in the guinea pig in vivo.
    Epilepsy research, 2004, Volume: 60, Issue:1

    Topics: Animals; Anticonvulsants; Cerebral Cortex; Convulsants; Electroencephalography; Epilepsy; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing; Hearing Loss; Male; Neuroprotective Agents; Pentylenetetrazole; Vinca Alkaloids

2004
Vinpocetine prevents 4-aminopyridine-induced changes in the EEG, the auditory brainstem responses and hearing.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2004, Volume: 115, Issue:12

    Topics: 4-Aminopyridine; Animals; Drug Interactions; Electroencephalography; Epilepsy; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hearing; Hearing Loss; Male; Nootropic Agents; Olivary Nucleus; Potassium Channel Blockers; Reaction Time; Vinca Alkaloids

2004
[Cavinton in epilepsy treatment and prevention].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2001, Volume: 101, Issue:11

    Topics: Adolescent; Adult; Anticonvulsants; Epilepsy; Functional Laterality; Humans; Treatment Outcome; Vinca Alkaloids

2001
[Use of cavinton in epilepsy].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1986, Volume: 86, Issue:6

    Topics: Adolescent; Adult; Anticonvulsants; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Epilepsy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Vinca Alkaloids

1986